ADVFN US – Market Content Editor
-
Tesla’s Robotaxi Trial in Austin Shows Strong Pricing Edge, Says William Blair
Tesla (NASDAQ:TSLA) offered a glimpse of its autonomous future with a robotaxi trial in Austin, showcasing both competitive pricing and a human-like driving experience, according to William Blair. The firm said the demonstration, held ahead of the public rollout in September, highlighted Tesla’s potential to gain market share using cost-efficient autonomous technology. “Robotaxi was half…
-
Novo Nordisk’s Ozempic Secures Canadian Approval for Kidney Disease Use
Novo Nordisk (NYSE:NVO) said Tuesday that Health Canada has expanded the label for its diabetes therapy Ozempic, granting approval for use in patients with chronic kidney disease. The new indication allows physicians to prescribe Ozempic to help slow the progression of kidney impairment, reduce the risk of kidney failure, and lower the likelihood of cardiovascular-related…
-
Peabody Energy Shares Surge After Canceling Anglo American Acquisition
Peabody Energy (NYSE:BTU) climbed 9% after the coal company announced it is walking away from its planned purchase of Anglo American Plc’s (LSE:AAL) steelmaking coal operations, citing a material adverse change. The move follows nearly five months of uncertainty tied to a March 31 ignition incident at Anglo’s Moranbah North Mine, where there is still…
-
Black Hills Shares Decline Following Merger Agreement With NorthWestern Energy
Black Hills Corp. (NYSE:BKH) dropped 3.6% to $58.20 in Tuesday’s premarket session after unveiling an all-stock merger with NorthWestern Energy Group (NASDAQ:NWE). The transaction, approved unanimously by both companies’ boards, will form a regulated utility player with a combined market capitalization of about $7.8 billion and an enterprise value of $15.4 billion. NorthWestern shares, which…
-
TEGNA Shares Gain After Nexstar Unveils $6.2 Billion Acquisition Plan
TEGNA Inc. (NYSE:TGNA) stock climbed 2.8% on Tuesday after Nexstar Media Group (NASDAQ:NXST) announced it would acquire the broadcaster in a $6.2 billion all-cash deal. The agreement values TEGNA at $22 per share, a 31% premium over the company’s 30-day average stock price ending August 8, 2025. TEGNA’s board has unanimously approved the transaction, which…
-
Opera Stock Climbs as Q2 Results Top Forecasts, Outlook Raised
Opera Limited (NASDAQ:OPRA) saw its shares gain nearly 3% in pre-market trading on Tuesday after the browser and AI-driven services company reported second-quarter results that came in ahead of Wall Street expectations and lifted its full-year guidance. Adjusted earnings per share came in at $0.26, well above analyst projections of $0.20. Revenue surged 30% year-over-year…
-
Viking Therapeutics Plunges 37% on Obesity Drug Trial Concerns
Shares of Viking Therapeutics (NASDAQ:VKTX) tumbled as much as 37% on Tuesday after the company released data from its Phase 2 VENTURE-Oral Dosing trial for its experimental oral obesity treatment. In contrast, Eli Lilly (NYSE:LLY) stock gained 1.5% as analysts emphasized the strength of its competing therapies. The trial results showed that Viking’s oral formulation…
-
Viking Holdings Tops Expectations with Strong Q2 Performance and 18.5% Revenue Growth
Viking Holdings Ltd (NYSE:VIK) announced second-quarter results on Tuesday that beat Wall Street forecasts, as both earnings and revenue came in ahead of consensus. Adjusted earnings per share were $0.99, topping analyst estimates of $0.79, while quarterly revenue reached $1.88 billion, up 18.5% from the same period a year earlier. Shares of the cruise operator…
-
PTC Therapeutics Shares Drop After FDA Rejects Vatiquinone Application
PTC Therapeutics, Inc. (NASDAQ:PTCT) saw its stock slide 5% after the U.S. Food and Drug Administration (FDA) declined to approve its New Drug Application (NDA) for vatiquinone, a treatment candidate for Friedreich’s ataxia. The decision came in the form of a Complete Response Letter (CRL). In its letter, the FDA said that PTC had not…
-
Premier Surpasses Q4 Earnings and Revenue Estimates, Shares Tick Up
Premier, Inc. (NASDAQ:PINC) reported fourth-quarter results on Tuesday that outperformed analyst expectations. Adjusted earnings per share came in at $0.46, beating estimates by $0.12, while revenue totaled $262.9 million, above the consensus of $247.13 million. Following the announcement, Premier’s shares rose slightly, gaining 0.25% in after-hours trading. The healthcare improvement company saw total net revenue…